首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:American journal of health-system pharmacy

缩写:AM J HEALTH-SYST PH

ISSN:1079-2082

e-ISSN:1535-2900

IF/分区:1.9/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引7122
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Joseph S Van Tuyl,Katherine E Di Palo,Trina Huynh et al. Joseph S Van Tuyl et al.
Purpose: To provide an overview of the manifestation and diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) and the treatment option acoramidis, including its pharmacology and clinical trial data. ...
Dhakrit Rungkitwattanakul,Nicholas Rebold,Sanaa Belrhiti et al. Dhakrit Rungkitwattanakul et al.
Purpose: To describe implementation strategies for a nephrotoxin stewardship service at Howard University Hospital aimed at reducing drug-associated acute kidney disease (D-AKD) in high-risk inpatients, as guided by the C...
Heeseung Hong,Sarah Hanigan Lewis,Darren M Triller et al. Heeseung Hong et al.
Purpose: Direct oral anticoagulants (DOACs) are highly effective in the treatment and prevention of thrombosis. Nevertheless, the prevalence of inappropriate DOAC dosing (ie, dosing not in alignment with Food and Drug Adm...
Kaylee Whytal,Ciera Isaman,Lindsey Meeks et al. Kaylee Whytal et al.
Purpose: This study aimed to evaluate the completeness and readability of patient education materials available through 3 widely used drug information databases and assess their potential impact on patient comprehension. ...
A Cameron Hill,Camryn Froerer A Cameron Hill
Purpose: This report describes the implementation, workflow structure, and outcomes of a centralized, investigational drug service (IDS)-led process for concomitant medication reviews in oncology clinical trials. This ini...
Hideaki Yashima,Takuya Araki,Akiko Kaneta et al. Hideaki Yashima et al.
Purpose: Tirabrutinib, an oral Bruton's tyrosine kinase inhibitor, is used in the treatment of relapsed or refractory primary central nervous system lymphoma (PCNSL) and other B cell malignancies. Although this medication...